Key result
Symptomatic SARS-CoV-2 reinfection in elite athletes shows no apparent cardiac abnormalities.
Why the study?
The actual frequency and risk factors of SARS-CoV-2 reinfection remain a matter of intense scientific discussion.
Case Report (n=3)
Elite athletes may be susceptible to early SARS-CoV-2 reinfection, though extensive cardiac screening in this small cohort revealed no structural or electrical abnormalities.
Early reinfection may occur in elite athletes without cardiac sequelae; hypothesis-generating and should not yet change practice.
OBJECTIVES: The actual frequency and the risk factors of SARS-CoV-2 reinfection is still a matter of intense scientific discussion. In this case series, we report three elite athletes who underwent COVID-19 reinfection with a short time frame. CASE PRESENTATIONS: As a part of contact tracing, three speed skaters (22-, 24-, and 29-year-old males) were found to be SARS-CoV-2 positive by polymerase chain reaction (PCR) tests. Later on, only one of the athletes experienced mild symptoms, such as fatigue, loss of smell and taste and subfebrility, while the other two athletes were asymptomatic. Following the quarantine period, detailed return-to-play examinations, including laboratory testing, ECG, 24-h Holter monitoring, transthoracic echocardiography and cardiac magnetic resonance imaging, revealed no apparent abnormality; therefore, the athletes restarted training. After a median of 74 days, all three athletes presented with typical symptoms of COVID-19, such as fever, marked fatigue and headache. SARS-CoV-2 PCR tests were performed again, showing recurrent positivity. Repeated return-to-play assessments were initiated, finding no relevant abnormality. Athletes were also tested for SARS-CoV-2 anti-nucleoprotein antibody titers, showing only modest increases following the second infection. CONCLUSIONS: We report a small cluster of elite athletes who underwent a PCR-proven SARS-CoV-2 reinfection. According to these findings, athletes may be considered as a high-risk group in terms of recurrent COVID-19.
No takes yet. Share an insight, caveat, or question.
Fülöp et al. (2022) conducted a case report in SARS-CoV-2 reinfection (n=3). SARS-CoV-2 reinfection was evaluated on Clinical presentation and cardiac evaluation upon reinfection. Three male elite speed skaters experienced PCR-proven symptomatic SARS-CoV-2 reinfection after a median of 74 days from their initial infection, with no apparent cardiac abnormalities.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: